{
"info": {
"nct_id": "NCT00777582",
"official_title": "A Phase I, Randomised, 2 Period Cross Over Study to Determine the Comparative Bioavailability of Two Different Oral Formulations of AZD2281 in Cancer Patients With Advanced Solid Tumours",
"inclusion_criteria": "* Histologically confirmed malignant advanced solid tumour, which is refractory to standard therapies (except Group 8 patients who must not be platinum refractory) or for which no suitable effective standard therapy exists\n* Patients must have adequate organ and bone marrow function measured within 7 days prior to administration of study treatment\n* Female patients must have evidence of non-child bearing status: negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing, or postmenopausal status\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 130 Years",
"exclusion_criteria": "* Patients receiving chemotherapy, radiotherapy (except for palliative reasons) or any other anti-cancer therapy within 4 weeks of the last dose prior to study entry. Patients may continue the use of biphosphonates for bone metastases and corticosteroids\n* Patients with symptomatic uncontrolled brain metastases\n* Major surgery within 2 weeks of starting study and patients must have recovered from any effects of any major surgery\n* Patients who are platinum refractory (Group 8 only)\n* Patients with myelodysplastic syndrome/acute myeloid leukaemia (Group 8 only).",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Histologically confirmed malignant advanced solid tumour, which is refractory to standard therapies (except Group 8 patients who must not be platinum refractory) or for which no suitable effective standard therapy exists",
"criterions": [
{
"exact_snippets": "Histologically confirmed malignant advanced solid tumour",
"criterion": "malignant advanced solid tumour",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "refractory to standard therapies",
"criterion": "tumour refractory status",
"requirement": {
"requirement_type": "refractory status",
"expected_value": "refractory to standard therapies"
}
},
{
"exact_snippets": "no suitable effective standard therapy exists",
"criterion": "availability of suitable effective standard therapy",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "Group 8 patients ... must not be platinum refractory",
"criterion": "platinum refractory status for Group 8 patients",
"requirement": {
"requirement_type": "refractory status",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Histologically confirmed malignant advanced solid tumour",
"criterion": "malignant advanced solid tumour",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"or_criteria": [
{
"exact_snippets": "refractory to standard therapies",
"criterion": "tumour refractory status",
"requirement": {
"requirement_type": "refractory status",
"expected_value": "refractory to standard therapies"
}
},
{
"exact_snippets": "no suitable effective standard therapy exists",
"criterion": "availability of suitable effective standard therapy",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
]
},
{
"or_criteria": [
{
"not_criteria": {
"exact_snippets": "Group 8 patients ... must not be platinum refractory",
"criterion": "platinum refractory status for Group 8 patients",
"requirement": {
"requirement_type": "refractory status",
"expected_value": false
}
}
},
{
"exact_snippets": "Group 8 patients ... must not be platinum refractory",
"criterion": "platinum refractory status for Group 8 patients",
"requirement": {
"requirement_type": "refractory status",
"expected_value": false
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Patients must have adequate organ and bone marrow function measured within 7 days prior to administration of study treatment",
"criterions": [
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Female patients must have evidence of non-child bearing status: negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing, or postmenopausal status",
"criterions": [
{
"exact_snippets": "Female patients must have evidence of non-child bearing status",
"criterion": "non-child bearing status",
"requirement": {
"requirement_type": "evidence",
"expected_value": true
}
},
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
},
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 7 days of study treatment"
}
},
{
"exact_snippets": "postmenopausal status",
"criterion": "menopausal status",
"requirement": {
"requirement_type": "status",
"expected_value": "postmenopausal"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Female patients must have evidence of non-child bearing status",
"criterion": "non-child bearing status",
"requirement": {
"requirement_type": "evidence",
"expected_value": true
}
},
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
},
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 7 days of study treatment"
}
}
]
},
{
"exact_snippets": "postmenopausal status",
"criterion": "menopausal status",
"requirement": {
"requirement_type": "status",
"expected_value": "postmenopausal"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 130 Years",
"criterions": [
{
"exact_snippets": "maximum age of 130 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 130,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 130 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 130,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Patients receiving chemotherapy, radiotherapy (except for palliative reasons) or any other anti-cancer therapy within 4 weeks of the last dose prior to study entry. Patients may continue the use of biphosphonates for bone metastases and corticosteroids",
"criterions": [
{
"exact_snippets": "Patients receiving chemotherapy",
"criterion": "chemotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "purpose",
"expected_value": "palliative reasons"
}
},
{
"exact_snippets": "Patients receiving ... any other anti-cancer therapy",
"criterion": "anti-cancer therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "Patients may continue the use of biphosphonates for bone metastases",
"criterion": "biphosphonates",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
},
{
"exact_snippets": "Patients may continue the use of ... corticosteroids",
"criterion": "corticosteroids",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Patients receiving chemotherapy",
"criterion": "chemotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"not_criteria": {
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "purpose",
"expected_value": "palliative reasons"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Patients receiving ... any other anti-cancer therapy",
"criterion": "anti-cancer therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
}
]
}
]
},
{
"not_criteria": {
"or_criteria": [
{
"exact_snippets": "Patients may continue the use of biphosphonates for bone metastases",
"criterion": "biphosphonates",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
},
{
"exact_snippets": "Patients may continue the use of ... corticosteroids",
"criterion": "corticosteroids",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Patients with symptomatic uncontrolled brain metastases",
"criterions": [
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "symptom presence",
"expected_value": true
}
},
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "symptom presence",
"expected_value": true
}
},
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
}
]
}
},
{
"identified_line": {
"line": "* Major surgery within 2 weeks of starting study and patients must have recovered from any effects of any major surgery",
"criterions": [
{
"exact_snippets": "Major surgery within 2 weeks of starting study",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time since surgery",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
},
{
"exact_snippets": "patients must have recovered from any effects of any major surgery",
"criterion": "recovery from major surgery",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"not_criteria": {
"exact_snippets": "Major surgery within 2 weeks of starting study",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time since surgery",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
}
},
{
"not_criteria": {
"exact_snippets": "patients must have recovered from any effects of any major surgery",
"criterion": "recovery from major surgery",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
}
]
}
},
{
"identified_line": {
"line": "* Patients who are platinum refractory (Group 8 only)",
"criterions": [
{
"exact_snippets": "Patients who are platinum refractory",
"criterion": "platinum refractory",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Group 8 only",
"criterion": "group",
"requirement": {
"requirement_type": "membership",
"expected_value": "8"
}
},
"then_criteria": {
"exact_snippets": "Patients who are platinum refractory",
"criterion": "platinum refractory",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Patients with myelodysplastic syndrome/acute myeloid leukaemia (Group 8 only).",
"criterions": [
{
"exact_snippets": "myelodysplastic syndrome",
"criterion": "myelodysplastic syndrome",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "acute myeloid leukaemia",
"criterion": "acute myeloid leukaemia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": "myelodysplastic syndrome",
"criterion": "myelodysplastic syndrome",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "acute myeloid leukaemia",
"criterion": "acute myeloid leukaemia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "Group 8 only",
"criterion": "Group",
"requirement": {
"requirement_type": "membership",
"expected_value": "Group 8"
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}